Skip to content

Clinical trials

Recruiting Urogenital Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Status: Recruiting Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20161
20181
20192
20201
20213
20225
20236
202410
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
University Health Network, Toronto3
Astellas Pharma Global Development, Inc.2
M.D. Anderson Cancer Center2
University of California, Irvine2
Wake Forest University Health Sciences2
Algemeen Ziekenhuis Maria Middelares1
Blue Earth Therapeutics Ltd1
British Columbia Cancer Agency1
Centre Hospitalier Universitaire de Nīmes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms42
Neoplasms16
Breast Neoplasms13
Prostatic Neoplasms12
Head and Neck Neoplasms10
Lung Neoplasms10
Neoplasms by Site10
Gastrointestinal Neoplasms9
Melanoma9
Male Urogenital Diseases8

Trials

Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.